Paper · 17889643

Non-oncogene addiction and the stress phenotype of cancer cells.

Solimini NL and 2 others. Cell, 2007. Cited by 297 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Non-oncogene addiction and the stress phenotype of cancer cells. Papers, record 17889643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17889643

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Non-oncogene addiction and the stress phenotype of cancer cells.; PubMed
Journal: Cell; PubMed
Year: 2007; PubMed
Publication types: Journal Article, Comment; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/17889643/; PubMed
DOI: https://doi.org/10.1016/j.cell.2007.09.007; PubMed
The journal: https://conductscience.org/library/journal-index/0413066; PubMed
Citations, by iCite: 297; iCite
Relative citation ratio, by iCite: 5.07; iCite
Revised in PubMed: 2017-11-16; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Solimini NL	Nicole L
2	Luo J	Ji
3	Elledge SJ	Stephen J

Source PubMed

Topics26

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Cell Transformation, Neoplastic	Major topic
DNA-Binding Proteins	Major topic
Gene Expression Regulation, Neoplastic	Major topic
Skin	Major topic
Skin Neoplasms	Major topic
Stress, Physiological	Major topic
Transcription Factors	Major topic
Animals
Carcinogens
Cell Line, Tumor
Cell Proliferation
Cell Survival
Genotype
Glucose
Heat Shock Transcription Factors
Humans
Mice
Mice, Knockout
Mutation
Phenotype
Protein Biosynthesis
Proto-Oncogene Proteins c-sis
Signal Transduction
Time Factors
Tumor Suppressor Protein p53
ras Proteins

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

Kind	PMID	Title	In Papers
Comment on	17,889,646	Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.	https://conductscience.org/library/papers/17889646

Source PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by203

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 297 citations.

PMID	Title	Journal	Year	In Papers	Source
42,938,890	REDD1 in Clear Cell Renal Cell Carcinoma: Linking Stress Adaptation, Proteostasis and Therapeutic Resistance.	Cancers (Basel)	2026	https://conductscience.org/library/papers/42938890	PubMed
42,314,908	Evolution of Hsp90 targeting: From stress biology to clinical translation.	Cell Stress Chaperones	2026	https://conductscience.org/library/papers/42314908	PubMed
42,257,744	Novel therapeutic targets at the crossroad between epigenetics and signal transduction pathways in B-cell lymphomas.	Clin Exp Med	2026	https://conductscience.org/library/papers/42257744	PubMed
41,914,024	Heat shock transcription factors in development and disease.	Dis Model Mech	2026	https://conductscience.org/library/papers/41914024	PubMed
41,836,014	Editorial: Exploiting non-oncogene addiction for overcoming drug resistance in metastatic tumors.	Front Pharmacol	2026	https://conductscience.org/library/papers/41836014	PubMed
41,835,397	Driving proteomic imbalance in malignancy provokes proteomic catastrophe and confers tumor suppression.	bioRxiv	2026	https://conductscience.org/library/papers/41835397	PubMed
41,815,915	Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias.	Front Pharmacol	2026	https://conductscience.org/library/papers/41815915	PubMed
41,727,155	Divergent condensates tune transcriptional responses during stress.	bioRxiv	2026	https://conductscience.org/library/papers/41727155	PubMed
41,539,306	Dominant-negative TP53 mutations potentiated by the HSF1-regulated proteostasis network.	Mol Cell	2026	https://conductscience.org/library/papers/41539306	PubMed
41,425,091	Emerging roles of stress granules in liver diseases: a comprehensive review.	Front Cell Dev Biol	2025	https://conductscience.org/library/papers/41425091	PubMed

1 to 10 of 203

See all 203 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
HSF1	3,297	PubTator's text mining	https://conductscience.org/library/genes/3297

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17889643

GET https://conductscience.org/api/papers/v1/17889643/cited_by?page=2

API reference For AI assistants